市場調查報告書
商品編碼
947409

免疫組織化學的全球市場

Immunohistochemistry

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 173 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

COVID-19危機中,2020年估算為18億美元的免疫組織化學的全球市場,在2020年∼2027年的期間中預計將以7.4%的年複合成長率成長,2027年之前達到30億美元。 市場區隔之一的抗體部門預測將以7.3%的年複合成長率增長,在分析期間結束前達到11億美元。

本報告提供免疫組織化學的市場調查,彙整市場定義和概要,市場成長的各種影響因素分析,市場規模的變化與預測,各種區分·地區·各主要國家的詳細分析,競爭環境,主要企業簡介等資料。

調查對象企業範例

  • Abcam PLC
  • Agilent Technologies, Inc.
  • Bio Sb, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • MilliporeSigma
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

目錄

  • i. 簡介,調查手法 、 調查範圍

II. 摘要整理

第1章 市場概要

  • 全球其他競爭公司的市場佔有率
  • 全球免疫組織化學的競爭市場佔有率方案(%):2019年及2025年
  • Covid-19的影響和即將到來的全球景氣衰退

第2章 主要企業

第3章 市場趨勢與推動因素

第4章 全球市場預測

  • 2012 vs 2020 vs 2027

III. 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 2012 vs 2020 vs 2027
  • 亞太地區
  • 其他地區

IV. 競爭

  • 企業簡介:38
目錄
Product Code: MCP12536

Abstract:

Global Immunohistochemistry Market to Reach $3 Billion by 2027

Amid the COVID-19 crisis, the global market for Immunohistochemistry estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$3 Billion by 2027, growing at a CAGR of 7.4% over the analysis period 2020-2027. Antibodies, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 8.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $543.2 Million, While China is Forecast to Grow at 6.9% CAGR

The Immunohistochemistry market in the U.S. is estimated at US$543.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$528.8 Million by the year 2027 trailing a CAGR of 6.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.

Kits Segment to Record 8.1% CAGR

In the global Kits segment, USA, Canada, Japan, China and Europe will drive the 8.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$311.3 Million in the year 2020 will reach a projected size of US$539.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$349.3 Million by the year 2027.

Select Competitors (Total 38 Featured) -

  • Abcam PLC
  • Agilent Technologies, Inc.
  • Bio Sb, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • MilliporeSigma
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Drug Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Drug Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Drug Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 22: USA Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 23: USA Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: USA 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 25: USA Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 28: Canada Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: Canada Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: Canada 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 31: Canada Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 34: Japan Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Japan Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Japan 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 37: Japan Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 40: China Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: China Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: China 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 43: China Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 46: Europe Current & Future Analysis for Immunohistochemistry by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 47: Europe Historic Review for Immunohistochemistry by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Europe 15-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 49: Europe Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 55: France Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: France Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: France 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 58: France Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 61: Germany Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Germany Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Germany 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 64: Germany Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 67: Italy Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Italy Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Italy 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 70: Italy Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 73: UK Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: UK Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: UK 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 76: UK Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 79: Rest of Europe Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Rest of Europe Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Rest of Europe 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 82: Rest of Europe Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Rest of Europe Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Rest of Europe 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 85: Asia-Pacific Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Asia-Pacific Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Asia-Pacific 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 88: Asia-Pacific Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Asia-Pacific Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Asia-Pacific 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 91: Rest of World Current & Future Analysis for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Rest of World Historic Review for Immunohistochemistry by Product - Antibodies, Reagents, Kits and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Rest of World 15-Year Perspective for Immunohistochemistry by Product - Percentage Breakdown of Value Sales for Antibodies, Reagents, Kits and Equipment for the Years 2012, 2020 & 2027
    • TABLE 94: Rest of World Current & Future Analysis for Immunohistochemistry by Application - Diagnostics and Drug Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of World Historic Review for Immunohistochemistry by Application - Diagnostics and Drug Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of World 15-Year Perspective for Immunohistochemistry by Application - Percentage Breakdown of Value Sales for Diagnostics and Drug Testing for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 38